Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19

Summary

This study is designed for single-center, randomized, open label, standard therapy controlled. 60 COVID-19 subjects with a treatment period of 10 days and follow-up until 28 days after enrollment.

Timeline

Start

2021-09-06

Primary completion

2023-06-01

Completion

2023-09-01

Drugs

Indications